Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04473690 · ClinicalTrials.gov registry record · Phase 1
KBP-201 COVID-19 Vaccine Trial in Healthy Volunteers
A Phase 1 study of Covid19, sponsored by KBio.
- Completed
- Registry status
- Phase 1
- Development phase
- 102
- Enrollment target
- 8
- Study locations
NCT04473690 is a Phase 1 study of Covid19 that has completed, run by KBio. The registered enrollment target is 102 participants, below the 2,701-participant average among 94 other Covid19 trials with a reported enrollment target (96% lower). The trial reports 8 study locations across 6 states.
The verdict
NCT04473690, a Phase 1 study of Covid19, has completed, sponsored by KBio.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 102 participants
- Enrollment target
- 8
- Study locations
Study Summary
This is an First In Human (FIH), observer-blinded, randomized, placebo-controlled, parallel group study to evaluate the safety and immunogenicity of KBP-COVID-19 plus CPG adjuvant vaccine in healthy adult subjects in 2 age groups, Part A (18-49 years) and Part B (50-85 years).
Conditions Studied
Interventions
- BIOLOGICAL Placebo
- BIOLOGICAL Low Dose of KBP-COVID-19
- BIOLOGICAL High Dose of KBP-COVID-19
Study Locations (8)
Texas
- PanAmerican Clinical Research - Brownsville
- ICON - San Antonio
- DM Clinical Research - Tomball
Florida
- Palm Beach Research Center - West Palm Beach
Idaho
- Velocity Clinical Research - Meridian
North Carolina
- PMG Research of Winston-Salem - Winston-Salem
Burlington/Ontario
- LMC Manna Research - Burlington
Point Claire, Quebec
- LMC Manna Research - Montreal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2020-12-30 |
| Est. Completion | 2022-10-14 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04473690
The ClinicalTrials.gov registry entry for NCT04473690 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,701-participant average among 94 other Covid19 trials with a reported enrollment target (96% lower). The listed sponsor is KBio, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Covid19 appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT04473690 reports 8 study locations spanning 6 distinct geographic areas - top geographies include Texas, Florida, Idaho.
Frequently Asked Questions
What is clinical trial NCT04473690 about?
NCT04473690 is a clinical study titled "KBP-201 COVID-19 Vaccine Trial in Healthy Volunteers". This is an First In Human (FIH), observer-blinded, randomized, placebo-controlled, parallel group study to evaluate the safety and immunogenicity of KBP-COVID-19 plus CPG adjuvant vaccine in healthy adult subjects in 2 age groups, Part A (18-49 years) and Part B (50-85 years).
What is the current status of trial NCT04473690?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 102 participants. The study started on 2020-12-30. Estimated completion is 2022-10-14.
What conditions does trial NCT04473690 study?
This clinical trial studies the following conditions: Covid19.
What interventions are being tested in trial NCT04473690?
The interventions under investigation include: Placebo (BIOLOGICAL), Low Dose of KBP-COVID-19 (BIOLOGICAL), High Dose of KBP-COVID-19 (BIOLOGICAL).
Who is sponsoring clinical trial NCT04473690?
This trial is sponsored by KBio, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04473690 being conducted?
This trial has 8 study locations across Florida, Idaho, North Carolina, Texas, Burlington/Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Covid19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Hyperpolarized 129Xe MRI of Survivors of COVID-19
ACTIVE NOT RECRUITING · Phase 1
-
Exercise Therapy in Cancer Patients Who Are Recovering From COVID-19
COMPLETED · Phase 1
-
RCT of Modified Qing Fei Pai Du Tang (mQFPD) for COVID-19
COMPLETED · Phase 1
-
Transfer of Infection Fighting Immune Cells Generated in the Laboratory to High Risk Patients With COVID-19 Infection
COMPLETED · Phase 1
-
COVID-19 Study of Safety and Tolerability of Alvelestat
COMPLETED · Phase 1
-
Safety and Immunogenicity Trial of an Oral SARS-CoV-2 Vaccine (VXA-CoV2-1) for Prevention of COVID-19 in Healthy Adults and Boost (VXA-CoV2-1.1-S) at 1 Year Post Initial Vaccination in Subset of Subjects
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.